vancomycin has been researched along with levofloxacin in 172 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (5.23) | 18.2507 |
| 2000's | 67 (38.95) | 29.6817 |
| 2010's | 64 (37.21) | 24.3611 |
| 2020's | 32 (18.60) | 2.80 |
| Authors | Studies |
|---|---|
| Inagaki, H; Kawakami, K; Kawato, HC; Matsuhashi, N; Miyauchi, RN; Miyauchi, S; Ohki, H; Takahashi, H; Takemura, M | 1 |
| Inagaki, H; Takahashi, H; Takemura, M | 1 |
| Appelbaum, PC; Bhawsar, SB; Bozdogan, B; de Souza, NJ; Desai, VN; Deshpande, PK; Gupte, SV; Hooper, DC; Jacobs, MR; Jha, R; Khorakiwala, HF; Patel, MV; Shetty, N; Shukla, MC; Strahilevitz, J; Yeole, RD | 1 |
| Clark, NC; Donlan, RM; Dumas, N; Jensen, B; Kohlerschmidt, D; Limberger, RJ; McDougal, LK; Musser, KA; Patel, JB; Shin, DH; Thompson, J; Weigel, LM; Zhu, W | 1 |
| Abbanat, D; Bush, K; Flamm, RK; Foleno, BD; Goldschmidt, RM; Macielag, MJ; Paget, SD; Webb, GC; Wira, E | 1 |
| Cohen, DE; Kanaya, F; Mayer, KH; Szumowski, JD | 1 |
| Fiett, J; Gniadkowski, M; Grzesiowski, P; Hryniewicz, W; Izdebski, R; Sadowy, E | 1 |
| Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Hashimoto, A; Lucien, E; Marlor, CW; Nelson, DM; Ou, Y; Pais, GC; Podos, SD; Pucci, MJ; Song, Y; Thanassi, JA; Thoma, CL; Wang, Q; Wiles, JA | 1 |
| Bradbury, BJ; Buechter, DD; Cheng, J; Deshpande, M; Mushtaq, G; Podos, SD; Pucci, MJ; Thanassi, JA; Thoma, CL; Vigliotti, GA | 1 |
| Cohen, MA; Ellsworth, E; Gage, JW; Gibson, GW; Gracheck, SJ; Hanna, DL; Huband, MD; Skerlos, LA; Stier, MA; Sulavik, MC; Zurack, M | 1 |
| Appelbaum, PC; Credito, K; Lin, G | 1 |
| Cottagnoud, M; Cottagnoud, P; Schaffner, T; Stucki, A; Winkelmann, V | 1 |
| Cho, JM; Chong, Y; Kim, CK; Kim, CM; Kim, JM; Lee, K; Ro, S; Yong, D; Yum, JH | 1 |
| Chang, CL; Jeong, J; Jeong, SH; Jung, HJ; Kim, HR; Kim, S; Lee, EY; Lee, JN; Shin, JH | 1 |
| Galang, MA; Gerding, DN; Hecht, DW; Johnson, S; Osmolski, JR; Sambol, SP | 1 |
| Liu, T; Lv, J; Qian, Y; Wang, Y | 1 |
| Ardanuy, C; Bouza, E; Calatayud, L; Cercenado, E; Fenoll, A; Liñares, J; Martín, R; Pallares, R | 1 |
| Jansen, WT; Milatovic, D; Verel, A; Verhoef, J | 1 |
| Yu, A; Zhang, Z; Zhou, W | 1 |
| Appelbaum, PC; Bogdanovich, T; Clark, C; Dewasse, B; Kosowska-Shick, K; McGhee, P | 1 |
| Clark, NC; Hageman, J; McDonald, LC; McDougal, LK; Patel, JB; Zhu, W | 1 |
| Fritsche, TR; Jones, RN; Sader, HS | 2 |
| Calvo, J; Martínez-Martínez, L; Salas, C | 1 |
| Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
| Danese, P; DeVito, J; Franceschi, F; Lawrence, L; Sutcliffe, J | 1 |
| Fujimoto, K; Hirokawa, Y; Kashimoto, S; Kato, S; Kinoshita, H; Kitadai, N; Kojima, T; Nakata, K; Tanaka, T | 1 |
| Laohavaleeson, S; Nicolau, DP; Tessier, PR | 1 |
| Chang, KY; Ho, YH; Hsieh, YC; Hsueh, PR; Huang, LM; Huang, YC; Lin, HC | 1 |
| Brickner, SJ; Duignan, J; Finegan, S; Girard, D; Huband, MD; Le, PT; Maloney, M; Schafer, J; Stone, GG; Wade, SK; Zaniewski, RP | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Benton, BM; Draghi, DC; Krause, KM; Pillar, C; Sahm, DF; Thornsberry, C | 1 |
| Benton, BM; Debabov, DV; Difuntorum, S; Krause, KM; Renelli, M; Wu, TX | 1 |
| Amsler, KM; Bush, K; Davies, TA; Jacobs, MR; Shang, W | 1 |
| Fowler, VG; Luperchio, SA; McCalla, C; Moise, PA; Robinson, DA; Sakoulas, G; Smyth, DS; Steenbergen, J | 1 |
| Biek, D; Ge, Y; Sahm, DF; Talbot, GH | 1 |
| Bradford, PA; Jones, CH; Mansour, TS; Petersen, PJ; Projan, SJ; Venkatesan, AM | 1 |
| Cui, L; Hiramatsu, K; Neoh, HM; Shoji, M | 1 |
| Bell, JM; Biedenbach, DJ; Jones, RN; Sader, HS; Turnidge, JD | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Hafkin, B; Hoban, DJ; Kaplan, N; Karlowsky, JA; Zhanel, GG | 1 |
| Brunner, LS; Haas, W; Lee, JC; Morris, TW; Pillar, CM; Zurenko, GE | 1 |
| Chen, H; Chen, M; Liu, Y; Ma, Y; Nichols, WW; Sun, W; Wang, H; Zhang, J; Zhao, C | 1 |
| Han, S; Hwang, JK; Lee, K; Rukayadi, Y; Yong, D | 1 |
| Inagaki, H; Ito, M; Kawakami, K; Matsuhashi, N; Miyauchi, R; Ohki, H; Takahashi, H; Takemura, M | 1 |
| Banevicius, MA; Crandon, JL; Koomanachai, P; Nicolau, DP; Peng, L | 1 |
| Arhin, FF; Draghi, DC; Moeck, G; Parr, TR; Pillar, CM; Sahm, DF | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cai, L; Gilbert, GL; Kong, F; Oftadeh, S; Xiao, M; Xu, X; Zhou, F | 1 |
| Chen, HC; King, CH; Lai, JF; Lauderdale, TL; Shiau, YR | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Amsler, KM; Bush, K; Foleno, BD; He, W; Lynch, AS; Macielag, MJ; Morrow, BJ | 1 |
| Bajaksouzian, S; Biek, D; Critchley, IA; Good, CE; Jacobs, MR; Jones, RN; Sader, HS; Windau, AR | 1 |
| Biedenbach, DJ; Jones, RN; Putnam, SD; Ross, JE | 1 |
| Ardanuy, C; Brito-Avô, A; Gonçalo-Marques, J; Liñares, J; Morais, A; Pires, R; Rolo, D; Santos-Sanches, I | 1 |
| Janechek, MJ; Jones, RN; Mendes, RE; Moet, GJ | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Aytemir, MD; Ozçelik, B | 1 |
| Bavari, S; Bowlin, TL; Butler, MM; Moir, DT; Panchal, RG; Peet, NP; Shinabarger, DL; Williams, JD | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Bradbury, BJ; Deshpande, M; Hashimoto, A; Kim, HY; Lucien, E; Nelson, DM; Pais, GC; Podos, SD; Pucci, MJ; Thanassi, JA; Wang, Q; Wiles, JA | 1 |
| Bae, KS; Chung, HY; Hong, J; Jung, JH; Kim, EL; Kim, HS; Li, F; Li, JL; Liu, J | 1 |
| Alm, RA; Barthlow, H; Brassil, P; Breen, J; Ciaccio, P; Comita-Prevoir, J; Cronin, M; Ehmann, DE; Fisher, SL; Geng, B; Godfrey, AA; Goteti, K; McNulty, J; Newman, JV; Reck, F | 1 |
| Bonvin, Y; Briet, S; Denis, A; Desroy, N; Drocourt, E; Durant, L; Escaich, S; Faivre, F; Floquet, S; Genevard, JM; Gerusz, V; LeFralliec, G; Moreau, F; Oliveira, C; Oxoby, M; Peltier, L; Prouvensier, L; Raymond, C; Saccomani, M; Sam-Sambo, V; Soulama-Mouze, C; Vongsouthi, V; Walton, A | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Bortolozzo, Lde S; de Castro Siqueira, AM; Jorge, SD; Palace-Berl, F; Pasqualoto, KF; Tavares, LC; Zorzi, RR | 1 |
| Chopra, S; Kushwaha, P; Modukuri, RK; Pasupuleti, M; Rao, KB; Sashidhara, KV; Shukla, PK; Singh, P; Soni, I | 1 |
| Bao, Y; Huang, X; Lan, S; Wang, T; Zhang, X; Zhu, S | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Lynch, AS; Ma, Z | 1 |
| Steenbergen, J; Tanaka, SK; Villano, S | 1 |
| Brozovic, A; Dowson, CG; Gazvoda, M; Košmrlj, J; Lloyd, A; Osmak, M; Proud, C; Roper, DI; Vajs, J | 1 |
| Bian, C; Chen, X; Hu, L; Hu, X; Liu, Y; Nie, T; Wu, Y; You, X | 1 |
| Aung, TT; Beuerman, RW; Cao, D; Koh, JJ; Lakshminarayanan, R; Li, J; Lim, F; Lin, S; Liu, S; Ren, L; Tan, DT; Verma, C; Wang, L; Wang, Y; Zou, H | 1 |
| Alverson, JB; Decato, D; Hoody, J; Klepacki, D; McGrath, K; Priestley, ND; Stierle, AA; Stierle, DB | 1 |
| Ashenden, S; Bender, A; Cokol, M; Karakoc, I; Kuru, N; Mason, DJ; Meral, S; Stott, I; Weinstein, ZB | 1 |
| Aung, TT; Beuerman, RW; Cao, D; Koh, JJ; Lakshminarayanan, R; Lim, F; Lin, S; Liu, S; Ren, L; Sin, WLW; Tan, DTH; Wang, L; Zhou, L | 1 |
| Clifford, M; Hind, C; Jamshidi, S; Nahar, K; Picconi, P; Rahman, KM; Sutton, JM; Wand, ME | 1 |
| Deshmukh, MS; Jain, N | 1 |
| Borra, RS; Chopra, S; Das, S; Dasgupta, A; Gatadi, S; Gour, J; Kaul, G; Madhavi, YV; Malasala, S; Nanduri, S; Shukla, M | 1 |
| Bishai, WR; Duan, G; Gunosewoyo, H; Liu, LL; Lun, S; Tang, J; Xiao, S; Yang, F; Yu, LF; Zhang, W | 1 |
| Bian, C; Chen, X; Hu, L; Hu, X; Liu, Y; Wang, C; Wu, Y; You, X; Zhang, Y | 1 |
| Amada, H; Endo, M; Hitaka, K; Kamitani, M; Masuko, A; Mihara, Y; Mima, M; Ohtake, N; Sugiyama, H; Takata, I; Takeuchi, T; Tamura, Y; Tanaka-Yamamoto, N; Ushiyama, F; Wada, R | 1 |
| Ahmad, MN; Akunuri, R; Chopra, S; Dasgupta, A; Kaul, G; Madhavi, YV; Malasala, S; Nanduri, S; Shukla, M | 1 |
| Bishai, WR; Gunosewoyo, H; Liu, LL; Lun, S; Tang, J; Wang, SS; Xiao, S; Yang, F; Yu, LF; Zhang, W | 1 |
| Chen, A; Cummings, JE; Duncan, LR; English, A; Koci, B; Li, L; Lindert, S; Lu, Y; Mann, CA; McElroy, CA; Mitton-Fry, MJ; Nolan, S; Okumu, A; Papa, JL; Ratigan, SC; Roth, B; Seffernick, JT; Slayden, RA; Vibhute, S; Wozniak, DJ; Yalowich, J | 1 |
| Dong, H; Fu, S; Li, H; Liu, L; Satoh, T; Wang, Y; Yuan, X; Zhang, C | 1 |
| Dewangan, RP; Ghosh, JK; Gupta, A; Habib, S; Mitra, K; Pant, G; Verma, DP; Verma, NK | 1 |
| Lohan, S; Mohammed, EHM; Parang, K; Tiwari, RK | 1 |
| Akhir, A; Chopra, S; Kaul, G; Meenu, MT; Radhakrishnan, KV; Shukla, M | 1 |
| Hayden, MK; Matushek, MG; Trenholme, GM | 1 |
| Eliopoulos, GM; Moellering, RC; Wennersten, CB | 1 |
| Biedenbach, DJ; Jones, RN | 1 |
| Palmer, SM; Rybak, MJ | 1 |
| Bryskier, A; Capper, T; Klugman, KP | 1 |
| Aikawa, N; Denno, R; Fujimoto, M; Hirata, AK; Ishibiki, K; Ishihara, R; Ishikawa, S; Iwai, S; Kinoshita, H; Koide, H; Kunimatsu, M; Manabe, T; Mashita, K; Mizuno, A; Morimoto, K; Mukaiya, M; Ohnishi, H; Ohtsuka, K; Sakaguchi, S; Shinagawa, N; Takuma, K; Tanimura, H; Umemoto, Y; Ushijima, Y; Yura, J | 1 |
| Entenza, JM; Glauser, MP; Moreillon, P; Vouillamoz, J | 2 |
| Tuohy, M; Washington, JA | 1 |
| Heisig, P; Jones, ME; Klootwijk, M; Schmitz, FJ; Verhoef, J; Visser, MR | 1 |
| Kang-Birken, SL | 1 |
| Bonner, D; Fung-Tomc, J; Gradelski, E; Kolek, B; Valera, L | 1 |
| Georgopoulos, A; Graninger, W; Grisold, A; Mueller-Uri, P; Presterl, E | 1 |
| Bisognano, C; Francois, P; Lew, DP; Schrenzel, J; Vaudaux, P | 1 |
| Akasaki, M; Blosser-Middleton, RS; Critchley, IA; Jones, ME; Karlowsky, JA; Sahm, DF; Thornsberry, C; Yamakita, J | 1 |
| Cirioni, O; D'Amato, G; Del Prete, MS; Ghiselli, R; Giacometti, A; Mocchegiani, F; Orlando, F; Saba, V; Scalise, G; Silvestri, C | 1 |
| Matoba, AY | 1 |
| Safdar, A | 1 |
| Akins, RL; Cha, R; Rybak, MJ | 1 |
| Cicek-Senturk, G; Erdem, I; Karagul, E; Yucesoy-Dede, B; Yuksel, S; Yuksel-Kocdogan, F | 1 |
| Arnold, FW; Wojda, B | 1 |
| Ariza, J; Cabellos, C; Doménech, A; Garcia, A; Gudiol, F; Murillo, O; Tubau, F | 1 |
| Cantón, E; Colombo Gainza, E; Gil Brusola, A; Gobernado, M; Ortiz Estévez, R; Sahuquillo Arce, JM | 1 |
| Hassoun, A; Ibrahim, F | 1 |
| De Vecchi, E; Drago, L; Gismondo, MR; Nicola, L | 1 |
| Abad, JL; Alió, JL; Fernandez, J; Ferrer, C; Rodríguez, A | 1 |
| Gutiérrez, F; Hernández, I; Masiá, M; Matoses, C; Murcia, A; Navarro, A; Padilla, S; Romero, I; Sánchez, V | 1 |
| Abe, H; Arakawa, Y; Fujikawa, H; Ishigami, T; Matsuoka, S; Miyagawa, M; Moriyama, M; Ryuzaki, H | 1 |
| Alqahtani, M; Ciccotelli, W; Cox, P; Low, D; Morris, S; Opavsky, M; Pillai, D; Poutanen, S | 1 |
| Gordon, YJ; Kowalski, RP; Mah, FS; Romanowski, EG; Shanks, RM | 1 |
| Araj, GF; Awar, GN; Baban, TA; Kanj, SS; Naba, MR; Tabbarah, ZA | 1 |
| Chamberlain, NR; Nguyen, VL; Shapiro, JA | 1 |
| Biek, D; Costello, AJ; Critchley, IA; Diekema, DJ; Doern, GV; Dohrn, CL; Heilmann, KP; Kroeger, JS; Riahi, F; Richter, SS | 1 |
| Garg, B; Kumar, V; Madan, M; Malhotra, R | 1 |
| Ergun, H; Köseoglu-Eser, O; Mamuk, S; Melli, M; Saribas, Z | 1 |
| Hsueh, PR; Ko, WC; Liao, CH; Lu, JJ | 1 |
| Abriouel, H; Benomar, N; Gálvez, A; Lavilla Lerma, L; Pérez Pulido, R; Sánchez Valenzuela, A | 1 |
| Blanco, AR; Papa, V; Spoto, CG; Sudano Roccaro, A | 1 |
| Baj, A; Beltramini, GA; Giannì, AB; Laganà, FC | 1 |
| Cheng, J; Hu, LF; Li, JB; Liu, LG; Ye, Y; Zhu, YL | 1 |
| Kaufman, E; Liska, D; Nandakumar, G; Rubinshteyn, V | 1 |
| Bolac, C; Brassat, S; Camus, M; Cante, V; Guillet, G; Paquier-Valette, C | 1 |
| Alqumber, MA | 1 |
| Cary, MS; Cluzet, VC; Fishman, NO; Lautenbach, E; Linkin, DR; Morales, KH; Nachamkin, I; Shih, NN | 1 |
| Balbuena Segura, AI; Corrales Fernández, MJ; Gea Velázquez de Castro, MT | 1 |
| Imöhl, M; van der Linden, M | 1 |
| Boyd, AS; Di Pentima, MC; Willis, ZI | 1 |
| Nesher, L; Prince, RA; Rolston, KV; Shelburne, SA; Wang, W | 1 |
| Bravo-Molina, A; Hernández-Quero, J; Linares-Palomino, JP; Lozano-Alonso, S; Ros-Díe, E; Vera-Arroyo, B | 1 |
| Jones, RN; Mendes, RE; Schuchert, JE | 1 |
| Cole, NC; Greenwood-Quaintance, KE; Harper, LW; Ihde, SM; Kohner, PC; Mushtaq, A; Patel, R; Strand, GJ; Virk, A | 1 |
| Bonavila Juan, C; Goenaga Sánchez, MÁ; Michelena Bengoechea, A; Zubeltzu Sese, B | 1 |
| García-Alvarez, R; Izquierdo-Barba, I; Vallet-Regí, M | 1 |
| Chen, HX; Luo, YP; Shen, YY; Song, LJ; Suo, L; Wang, R | 1 |
| Kempker, RR; Kumar, S; Mgbemena, O; Serota, DP; Weiss, DS; Wozniak, JE | 1 |
| Decousser, JW; Dowzicky, MJ; Fines-Guyon, M; Soussy, CJ; Woerther, PL | 1 |
| Chen, F; Chen, J; Zhang, Z | 1 |
| Bae, IG; Cho, OH; Choi, SH; Chong, YP; Kang, KC; Kim, DY; Kim, SH; Kim, YS; Lee, JH; Lee, MS; Lee, SO; Lee, YM; Moon, C; Park, KH; Park, SY; Ryu, BH; Woo, JH | 1 |
| Benedetto, C; Bertero, L; Borella, F; Carosso, A; Cosma, S; Fassio, F; Ingala, A; Maina, A; Robba, T | 1 |
| Chihara, Y; Egawa, S; Fujimoto, K; Fujimoto, Y; Goto, H; Hamasuna, R; Hanaki, H; Hayami, H; Hiroshi, M; Hiyama, Y; Homma, Y; Inatomi, H; Ishihara, S; Ishikawa, K; Ito, N; Ito, T; Kamei, J; Kanamaru, S; Kato, M; Kawanishi, H; Kimura, T; Kiyota, H; Kobayashi, K; Koda, S; Komeda, H; Masue, T; Masumori, N; Matsubara, A; Matsukawa, M; Matsumoto, K; Matsumoto, T; Minamitani, S; Mita, K; Mitsumori, K; Miyazaki, J; Mori, K; Nishimura, K; Nishiyama, H; Oka, Y; Okumura, K; Sato, J; Shigeta, M; Shoji, K; Takahashi, K; Takahashi, S; Takahashi, Y; Takenaka, T; Tanaka, K; Tateda, K; Togo, Y; Torimoto, K; Tsugawa, M; Uehara, S; Wada, K; Watanabe, S; Yamada, D; Yamada, H; Yamamoto, S; Yamashita, M; Yasuda, M; Yasufuku, T | 1 |
| Cheng, JW; Fan, X; Hou, X; Kudinha, T; Liang, GW; Liu, C; Shao, DH; Su, JR; Wang, Y; Wei, M; Xiao, M; Xiong, ZJ; Xu, YC; Yang, CX; Yang, QW; Yu, SY | 1 |
| Conterno, LO; Dayer, M; Gonzalez Garay, AG; Martí-Amarista, CE; Martí-Carvajal, AJ | 1 |
| Chudzik-Rząd, B; Malm, A; Paneth, A; Plech, T; Trotsko, N; Wujec, M | 1 |
| Azadi, H; Darabi, E; Fathi, S; Ghanei, M; Ghazale, AH; Ghazvini, A; Izadi, M; Jafari, R; Movaseghi, F; Mozafari, A; Panahi, Y; Parsaei, MR; Ranjkesh, MH; Rezapour, M; Saadat, SH; Salesi, M; Vahedi, E; Zand, N | 1 |
| Arif, S; Bishawi, M; Maskarinec, SA; Milano, C; Miller, RA; Mourad, A | 1 |
| D'Angeli, F; Di Salvatore, V; Genovese, C; Nicolosi, D; Tempera, G | 1 |
| Dangor, Y; Ismail, F; Kwatra, G; Madhi, SA; Mbelle, N; Said, M | 1 |
| Chen, G; Dong, C; Dong, Y; Fang, Y; Tao, X; Wu, S; Xu, K; Yu, Z; Zhang, L; Zhou, X; Zhu, F | 1 |
| Chen, HC; Chen, KJ; Chen, YP; Chong, YJ; Kang, EY; Lai, CC; Liu, L; Sun, MH; Wu, WC | 1 |
| Congia, S; Conte, M; Dessì, G; Donadu, MG; Marongiu, G; Mazzarello, V; Verderosa, V; Verona, M | 1 |
| Chen, YH; Chen, YS; Cheng, SH; Hsueh, PR; Ko, WC; Lee, CM; Lee, WS; Lee, YL; Lin, CN; Lin, CY; Liu, CP; Lu, MC; Lu, PL; Shao, PL; Sheng, WH; Shi, ZY; Tang, HJ; Tsai, YT; Tseng, SH; Wang, FD; Wang, LS; Wu, TS; Yen, MY | 1 |
| Imai, S; Ishibe, K; Itohara, K; Matsubara, K; Nakagawa, S; Nakagawa, T; Osada, Y; Shimazaki, A; Takao, S; Yonezawa, A | 1 |
| Chen, Y; Hu, J; Liu, J; Wang, F; Zhong, C; Zhou, H | 1 |
| Fan, X; Kang, X; Luo, S; Luo, X; Wang, G; Wei, Y; Zhao, S | 1 |
| Bartoszewicz, M; Brożyna, M; Dudek-Wicher, R; Dydak, K; Junka, A; Madziała, M; Oleksy-Wawrzyniak, M; Paleczny, J | 1 |
| Guo, S; Li, X; Li, Y; Shao, J; Tian, M; Tong, H; Wei, M; Xu, B; Yan, B | 1 |
| Aguirre-Burciaga, E; Alcaraz-Espejel, M; Avilés-Benítez, LK; Barlandas-Rendón, NRE; Barroso-Herrera-Y-Cairo, IE; Bocanegra-Ibarias, P; Bolado-Martinez, E; Camacho-Ortiz, A; Carnalla-Barajas, MN; Cetina-Umaña, CM; Cobos-Canul, DI; Colin, C; Couoh-May, CA; Duarte, L; Echaniz-Aviles, G; Escalante-Armenta, SP; Feliciano-Guzmán, JM; Garza-González, E; Gil, M; Gómez-Choel, AC; Hernández-Cordova, IY; Hernández-Dueñas, AMDR; Huirache-Villalobos, GS; López, D; Lopez, L; López-García, M; López-Gutiérrez, E; López-Jácome, LE; Martínez-Gamboa, RA; Mena-Ramirez, JP; Molina, A; Mora-Jiménez, I; Morales-de-la-Peña, CT; Morfin-Otero, R; Munoz, S; Newton-Sánchez, OA; Ortiz-Brizuela, E; Padilla-Ibarra, C; Peralta-Catalán, R; Perez-Ricardez, ML; Ponce-de-Leon, A; Quevedo-Ramos, MA; Quintanilla-Cazares, LJ; Rincón-Zuno, J; Rivera-Ferreira, MC; Rodriguez-Noriega, E; Rodriguez-Zulueta, P; Rojas-Larios, F; Romero, D; Ruiz-Gamboa, LA; Soto, A; Tinoco, JC; Velázquez-Acosta, MDC; Zubiate, H | 1 |
| Liu, CL; Liu, XT; Qiu, J; Wen, ZQ; Zhang, ZH; Zhu, SY | 1 |
| Amelot, M; Bougeard, S; Jouy, E; Keita, A; Kempf, I; Laurentie, J; Mourand, G; Serror, P | 1 |
| Bleick, C; Daffinee, KE; LaPlante, KL; Piehl, EC | 1 |
| Fukushima, S; Gotoh, K; Hagiya, H; Otsuka, F; Uda, K | 1 |
| Álvarez-Pérez, S; Anega, B; Blanco, JL; García, ME; Hernández, M | 1 |
6 review(s) available for vancomycin and levofloxacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic.
Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Drug Discovery; Humans; Microbial Sensitivity Tests; Molecular Conformation; Tetracyclines | 2016 |
[Recurrent endocarditis due to Brevibacterium casei: case presentation and a review of the literature].
Topics: Actinomycetales Infections; Anti-Bacterial Agents; Aortic Valve Stenosis; Bacteremia; Brevibacterium; Ceftriaxone; Disease Susceptibility; Drug Therapy, Combination; Emergencies; Endocarditis, Bacterial; Facial Dermatoses; Gentamicins; Humans; Levofloxacin; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Recurrence; Tetracycline; Vancomycin; Wound Infection | 2017 |
Osteomyelitis of the pubic symphysis caused by methicillin-resistant Staphylococcus aureus after vaginal delivery: a case report and literature review.
Topics: Adult; Anti-Bacterial Agents; Delivery, Obstetric; Female; Fever; Humans; Levofloxacin; Magnetic Resonance Imaging; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Osteomyelitis; Postpartum Period; Pregnancy; Pseudomonas aeruginosa; Pubic Symphysis; Rare Diseases; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2019 |
A comparison of different antibiotic regimens for the treatment of infective endocarditis.
Topics: Anti-Bacterial Agents; Endocarditis, Bacterial; Female; Fosfomycin; Humans; Imipenem; Levofloxacin; Male; Penicillins; Randomized Controlled Trials as Topic; Vancomycin | 2020 |
Late onset periprosthetic joint infection of the knee caused by Streptococcus anginosus. Case presentation and literature review.
Topics: Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Humans; Knee Joint; Levofloxacin; Male; Reoperation; Streptococcal Infections; Streptococcus anginosus; Vancomycin | 2021 |
3 trial(s) available for vancomycin and levofloxacin
| Article | Year |
|---|---|
In vitro activity of ceftobiprole against pathogens from two phase 3 clinical trials of complicated skin and skin structure infections.
Topics: Anti-Bacterial Agents; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Skin Diseases, Bacterial; Staphylococcus | 2008 |
Microbiological and genotypic analysis of methicillin-resistant Staphylococcus aureus bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Daptomycin; Endocarditis, Bacterial; Genotype; Hemolysin Proteins; Humans; Methicillin Resistance; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Vancomycin | 2008 |
Limited efficacy of a nonrestricted intervention on antimicrobial prescription of commonly used antibiotics in the hospital setting: results of a randomized controlled trial.
Topics: Aged; Anti-Bacterial Agents; Carbapenems; Counseling; Drug Prescriptions; Drug Utilization; Female; Guideline Adherence; Hospitals; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Organizational Policy; Vancomycin | 2008 |
163 other study(ies) available for vancomycin and levofloxacin
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of 5-amino-6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-8-methylquinolonecarboxylic acid antibacterials having fluorinated 7-[(3R)-3-(1-aminocyclopropan-1-yl)pyrrolidin-1-yl] substituents.
Topics: Anti-Bacterial Agents; Cyclopropanes; Drug Resistance, Bacterial; Gram-Positive Bacteria; Microbial Sensitivity Tests; Quinolones; Stereoisomerism; Structure-Activity Relationship | 2003 |
Synthesis and antibacterial activity of novel 6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-4-oxoquinoline-3-carboxylic acids bearing cyclopropane-fused 2-amino-8-azabicyclo[4.3.0]nonan-8-yl substituents at the C-7 position.
Topics: Anti-Infective Agents; Cyclopropanes; DNA Topoisomerase IV; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Quinolones; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2004 |
A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Clinical Trials, Phase I as Topic; Dogs; Drug Resistance, Multiple, Bacterial; Female; Fluoroquinolones; Half-Life; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Methicillin Resistance; Mice; Microbial Sensitivity Tests; Mutation; Prodrugs; Quinolizines; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Stereoisomerism; Structure-Activity Relationship; Vancomycin Resistance | 2005 |
High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
Topics: Acetamides; Aminoglycosides; Biofilms; Catheters, Indwelling; Chloramphenicol; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Female; Fluoroquinolones; Humans; Linezolid; Macrolides; Microbial Sensitivity Tests; Micrococcus; Middle Aged; Morganella morganii; Oxazolidinones; Penicillins; Pseudomonas aeruginosa; Rifampin; Staphylococcus aureus; Tetracyclines; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Catheterization; Vancomycin; Vancomycin Resistance | 2007 |
In vitro antibacterial activity of the pyrrolopyrazolyl-substituted oxazolidinone RWJ-416457.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Staphylococcus; Streptococcus | 2007 |
Treatment and outcomes of infections by methicillin-resistant Staphylococcus aureus at an ambulatory clinic.
Topics: Adult; Ambulatory Care Facilities; Anti-Bacterial Agents; Boston; Female; HIV Infections; Humans; Male; Methicillin Resistance; Middle Aged; Soft Tissue Infections; Staphylococcal Infections; Staphylococcal Skin Infections; Staphylococcus aureus; Treatment Outcome | 2007 |
Clonal diversity and resistance mechanisms in tetracycline-nonsusceptible Streptococcus pneumoniae isolates in Poland.
Topics: Bacterial Proteins; Cell Lineage; DNA Transposable Elements; Genetic Variation; Poland; Streptococcus pneumoniae; Tetracycline; Tetracycline Resistance | 2007 |
Isothiazoloquinolones with enhanced antistaphylococcal activities against multidrug-resistant strains: effects of structural modifications at the 6-, 7-, and 8-positions.
Topics: Animals; Anti-Bacterial Agents; Cell Line, Tumor; Drug Resistance, Multiple, Bacterial; Female; Humans; Methicillin Resistance; Mice; Quinolones; Staphylococcus aureus; Structure-Activity Relationship; Thiazoles; Topoisomerase II Inhibitors | 2007 |
In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens.
Topics: Animals; Anti-Infective Agents; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Quinolones; Thiazoles | 2007 |
In vitro and in vivo activities of PD 0305970 and PD 0326448, new bacterial gyrase/topoisomerase inhibitors with potent antibacterial activities versus multidrug-resistant gram-positive and fastidious organism groups.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Resistance, Multiple; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Microbial Sensitivity Tests; Pyrrolidines; Quinazolinones; Topoisomerase II Inhibitors | 2007 |
Antistaphylococcal activity of DX-619 alone and in combination with vancomycin, teicoplanin, and linezolid assessed by time-kill synergy testing.
Topics: Acetamides; Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Linezolid; Microbial Sensitivity Tests; Oxazolidinones; Pyrrolidines; Quinolones; Staphylococcus aureus; Teicoplanin; Time Factors; Vancomycin | 2007 |
Daptomycin produces an enhanced bactericidal activity compared to ceftriaxone, measured by [3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall.
Topics: Animals; Anti-Bacterial Agents; Bacteriolysis; Ceftriaxone; Cell Wall; Cerebrospinal Fluid; Choline; Daptomycin; Disease Models, Animal; Humans; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillin Resistance; Rabbits; Streptococcus pneumoniae; Treatment Outcome; Tritium | 2007 |
In vitro activities of CG400549, a novel FabI inhibitor, against recently isolated clinical staphylococcal strains in Korea.
Topics: Acetamides; Anti-Infective Agents; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enzyme Inhibitors; Humans; In Vitro Techniques; Korea; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Pyridines; Staphylococcus; Staphylococcus aureus; Thienopyridines; Thiophenes | 2007 |
Prevalence, characteristics, and molecular epidemiology of macrolide and fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae at five tertiary-care hospitals in Korea.
Topics: Anti-Bacterial Agents; Community-Acquired Infections; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Fluoroquinolones; Genes, Bacterial; Hospitals; Humans; Korea; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Molecular Epidemiology; Mutation; Ofloxacin; Pneumococcal Infections; Polymerase Chain Reaction; Prevalence; Reserpine; Respiratory Tract Infections; Retrospective Studies; Streptococcus pneumoniae | 2007 |
In vitro activities of 15 antimicrobial agents against 110 toxigenic clostridium difficile clinical isolates collected from 1983 to 2004.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Drug Resistance, Bacterial; Enterocolitis, Pseudomembranous; Humans; Microbial Sensitivity Tests; United States | 2007 |
Synthesis and evaluation of amphiphilic cationic quinine-derived for antibacterial activity against methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cations; Drug Evaluation, Preclinical; Methicillin Resistance; Microbial Sensitivity Tests; Quinine; Staphylococcus aureus | 2007 |
Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain.
Topics: Anti-Bacterial Agents; Clone Cells; Drug Resistance, Multiple, Bacterial; Electrophoresis, Polyacrylamide Gel; Erythromycin; Genes, Bacterial; Microbial Sensitivity Tests; Phenotype; Pneumococcal Infections; Serotyping; Spain; Streptococcus pneumoniae; Tetracycline Resistance | 2007 |
In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Europe; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes; Vancomycin Resistance; Viridans Streptococci | 2007 |
Synthesis and structure-activity relationship of 7-(substituted)-aminomethyl-4-quinolone-3-carboxylic acid derivatives.
Topics: Anti-Bacterial Agents; Carboxylic Acids; Drug Design; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Structure; Quinolones; Salmonella; Shigella boydii; Staphylococcus aureus; Stereoisomerism; Streptococcus; Structure-Activity Relationship | 2007 |
Antistaphylococcal activity of CG400549, a new experimental FabI inhibitor, compared with that of other agents.
Topics: Acetamides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Multiple, Bacterial; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enzyme Inhibitors; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Pyridines; Staphylococcus aureus; Thienopyridines; Thiophenes; Virginiamycin | 2007 |
Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbon-Oxygen Ligases; Conjugation, Genetic; DNA Transposable Elements; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Humans; Michigan; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Restriction Mapping; Staphylococcal Infections; Staphylococcus aureus; Vancomycin Resistance | 2008 |
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ceftaroline; Cephalosporins; Community-Acquired Infections; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; United States | 2008 |
Activity of Tigecycline against Coryneform Bacteria of Clinical Interest and Listeria monocytogenes.
Topics: Actinomycetales; Anti-Bacterial Agents; Humans; Listeria monocytogenes; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2008 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
In vitro activities of the Rx-01 oxazolidinones against hospital and community pathogens.
Topics: Anti-Infective Agents; Bacteria; Community-Acquired Infections; Cross Infection; Enterococcus; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones; Respiratory System; Staphylococcus; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae | 2008 |
Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Diterpenes; Dose-Response Relationship, Drug; Drug Design; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Mice; Microbial Sensitivity Tests; Molecular Structure; Pleuromutilins; Polycyclic Compounds; Solubility; Stereoisomerism; Water | 2008 |
Pharmacodynamic characterization of ceftobiprole in experimental pneumonia caused by phenotypically diverse Staphylococcus aureus strains.
Topics: Animals; Anti-Bacterial Agents; Cephalosporins; Community-Acquired Infections; Cross Infection; Disease Models, Animal; Drug Resistance, Bacterial; Female; Humans; Methicillin Resistance; Mice; Mice, Inbred BALB C; Phenotype; Pneumonia, Staphylococcal; Staphylococcus aureus | 2008 |
Clonal spread of highly beta-lactam-resistant Streptococcus pneumoniae isolates in Taiwan.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Genotype; Humans; Microbial Sensitivity Tests; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; Taiwan | 2008 |
In vitro antibacterial activity of CE-156811, a novel analog derived from hygromycin A.
Topics: Acetamides; Anti-Bacterial Agents; Cinnamates; Dioxoles; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Hygromycin B; In Vitro Techniques; Linezolid; Microbial Sensitivity Tests; Molecular Structure; Oxazolidinones | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Prospective Studies; Staphylococcus aureus; Streptococcus; Streptococcus pneumoniae; United States | 2008 |
In vitro activity of telavancin against resistant gram-positive bacteria.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; In Vitro Techniques; Lipoglycopeptides; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus; Streptococcus | 2008 |
In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; United States | 2008 |
Establishment of in vitro susceptibility testing methodologies and comparative activities of piperacillin in combination with the penem {beta}-lactamase inhibitor BLI-489.
Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactamase Inhibitors; Drug Combinations; Enzyme Inhibitors; Humans; Lactams; Microbial Sensitivity Tests; Piperacillin | 2009 |
Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Chromosome Walking; DNA-Binding Proteins; Genetic Engineering; Genome, Bacterial; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2009 |
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
Topics: Anti-Bacterial Agents; Asia; Drug Resistance, Bacterial; Europe; Gram-Positive Bacteria; Humans; Latin America; Microbial Sensitivity Tests; North America; Pacific Ocean; Quality Control; Teicoplanin; Vancomycin | 2009 |
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
Topics: Anti-Bacterial Agents; Enterococcus faecalis; Europe; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Hospitalization; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrimidines; Staphylococcus aureus; Streptococcus; United States | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
AFN-1252, a FabI inhibitor, demonstrates a Staphylococcus-specific spectrum of activity.
Topics: Anti-Bacterial Agents; Benzofurans; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Enterobacteriaceae; Enterococcus; Microbial Sensitivity Tests; Moraxella catarrhalis; Pyrones; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Staphylococcus epidermidis; Streptococcus pneumoniae | 2009 |
Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria.
Topics: Anti-Bacterial Agents; Azepines; Bacteria, Anaerobic; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 2009 |
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
Topics: Anti-Bacterial Agents; China; Cities; Drug Resistance, Multiple, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2009 |
In vitro activities of panduratin A against clinical Staphylococcus strains.
Topics: Anti-Bacterial Agents; Chalcones; Humans; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus; Zingiberaceae | 2009 |
Design, synthesis and biological evaluations of novel 7-[3-(1-aminocycloalkyl)pyrrolidin-1-yl]-6-desfluoro-8-methoxyquinolones with potent antibacterial activity against multi-drug resistant Gram-positive bacteria.
Topics: Anti-Bacterial Agents; Drug Design; Drug Resistance, Multiple; Gram-Positive Bacteria; Microbial Sensitivity Tests; Quinolones; Structure-Activity Relationship | 2009 |
Pharmacodynamic profile of tigecycline against methicillin-resistant Staphylococcus aureus in an experimental pneumonia model.
Topics: Animals; Anti-Bacterial Agents; Female; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Minocycline; Pneumonia; Staphylococcal Infections; Tigecycline | 2009 |
Comparative in vitro activity profile of oritavancin against recent gram-positive clinical isolates.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus faecium; Glycopeptides; Gram-Positive Bacteria; Humans; Lipoglycopeptides; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Distribution of serotypes, genotypes, and resistance determinants among macrolide-resistant Streptococcus pneumoniae isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Child, Preschool; DNA Transposable Elements; Drug Resistance, Bacterial; Erythromycin; Genotype; Humans; Macrolides; Microbial Sensitivity Tests; New South Wales; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae | 2010 |
Comparative in vitro activities of nemonoxacin (TG-873870), a novel nonfluorinated quinolone, and other quinolones against clinical isolates.
Topics: Anti-Bacterial Agents; Aza Compounds; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Moxifloxacin; Quinolines; Quinolones; Taiwan | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
In vitro antibacterial activities of JNJ-Q2, a new broad-spectrum fluoroquinolone.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Design; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Methicillin-Resistant Staphylococcus aureus; Streptococcus pneumoniae | 2010 |
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Communicable Diseases, Emerging; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; United States | 2010 |
In vitro activity of fidaxomicin (OPT-80) tested against contemporary clinical isolates of Staphylococcus spp. and Enterococcus spp.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Resistance, Bacterial; Enterococcus; Fidaxomicin; Humans; In Vitro Techniques; Staphylococcus | 2010 |
Emergence of ciprofloxacin-nonsusceptible Streptococcus pyogenes isolates from healthy children and pediatric patients in Portugal.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Outer Membrane Proteins; Bacterial Typing Techniques; Carrier Proteins; Child; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Molecular Epidemiology; Norfloxacin; Point Mutation; Portugal; Streptococcal Infections; Streptococcus pyogenes | 2010 |
In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Daptomycin; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Linezolid; Lipoglycopeptides; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Virginiamycin | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A study of cytotoxicity of novel chlorokojic acid derivatives with their antimicrobial and antiviral activities.
Topics: Animals; Anti-Infective Agents; Antiviral Agents; Bacteria; Cell Line; Chlorocebus aethiops; Drug Evaluation, Preclinical; Fungi; Herpesvirus 1, Human; Mannich Bases; Microbial Sensitivity Tests; Parainfluenza Virus 3, Human; Pyrones; Spectrum Analysis; Vero Cells | 2010 |
Comparative in vitro activity profiles of novel bis-indole antibacterials against gram-positive and gram-negative clinical isolates.
Topics: Anti-Bacterial Agents; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Indoles; Microbial Sensitivity Tests | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Exploration of the activity of 7-pyrrolidino-8-methoxyisothiazoloquinolones against methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Anti-Bacterial Agents; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Escherichia coli; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pyrrolidines; Quinolones; Stereoisomerism; Structure-Activity Relationship; Thiazoles; Topoisomerase II Inhibitors | 2011 |
Antibacterial polyketides from the jellyfish-derived fungus Paecilomyces variotii.
Topics: Animals; Anti-Bacterial Agents; Benzofurans; Drug Resistance, Multiple; Indans; Macrolides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Oceans and Seas; Paecilomyces; Scyphozoa; Vibrio parahaemolyticus | 2011 |
Novel N-linked aminopiperidine inhibitors of bacterial topoisomerase type II with reduced pK(a): antibacterial agents with an improved safety profile.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Biological Availability; Dioxanes; DNA Topoisomerase IV; Dogs; Drug Resistance, Bacterial; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Piperidines; Quinolones; Staphylococcal Infections; Stereoisomerism; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2012 |
From triclosan toward the clinic: discovery of nonbiocidal, potent FabI inhibitors for the treatment of resistant bacteria.
Topics: Animals; Anti-Infective Agents, Local; Benzamides; Cells, Cultured; Dogs; Drug Evaluation, Preclinical; Drug Resistance, Multiple, Bacterial; Enoyl-(Acyl-Carrier-Protein) Reductase (NADH); Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Phenyl Ethers; Rats; Structure-Activity Relationship; Triclosan | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Exploring 5-nitrofuran derivatives against nosocomial pathogens: synthesis, antimicrobial activity and chemometric analysis.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Cross Infection; Dose-Response Relationship, Drug; Fungi; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Nitrofurans; Principal Component Analysis; Structure-Activity Relationship | 2014 |
Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus.
Topics: | 2015 |
Synthesis and biological evaluation of levofloxacin core-based derivatives with potent antibacterial activity against resistant Gram-positive pathogens.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Penicillin Resistance; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship | 2015 |
Development of a Dual-Acting Antibacterial Agent (TNP-2092) for the Treatment of Persistent Bacterial Infections.
Topics: Anti-Bacterial Agents; Bacterial Infections; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Rifamycins; Staphylococcus aureus; Structure-Activity Relationship | 2016 |
Diaryltriazenes as antibacterial agents against methicillin resistant Staphylococcus aureus (MRSA) and Mycobacterium smegmatis.
Topics: Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mycobacterium smegmatis; Triazenes | 2017 |
Synthesis and in vitro activity of dicationic indolyl diphenyl ethers as novel potent antibiotic agents against drug-resistant bacteria.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Phenyl Ethers; Structure-Activity Relationship; Vancomycin Resistance | 2017 |
Symmetrically Substituted Xanthone Amphiphiles Combat Gram-Positive Bacterial Resistance with Enhanced Membrane Selectivity.
Topics: Animals; Anti-Bacterial Agents; Cornea; Drug Resistance, Bacterial; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Staphylococcal Infections; Surface-Active Agents; Xanthones | 2017 |
The Berkeleylactones, Antibiotic Macrolides from Fungal Coculture.
Topics: Anti-Bacterial Agents; Coculture Techniques; Macrolides; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Penicillium; Streptococcus pneumoniae; Streptococcus pyogenes | 2017 |
Prediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure.
Topics: Anti-Bacterial Agents; Drug Interactions; Molecular Structure | 2017 |
Semisynthetic Flavone-Derived Antimicrobials with Therapeutic Potential against Methicillin-Resistant Staphylococcus aureus (MRSA).
Topics: Animals; Anti-Bacterial Agents; Arginine; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Membrane; Cell Survival; Drug Resistance, Bacterial; Fibroblasts; Flavones; Hemolysis; Humans; Keratitis; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred C57BL; Microbial Sensitivity Tests; Molecular Mimicry; Rabbits; Staphylococcus aureus; Structure-Activity Relationship | 2017 |
Triaryl Benzimidazoles as a New Class of Antibacterial Agents against Resistant Pathogenic Microorganisms.
Topics: Anti-Bacterial Agents; Benzimidazoles; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; HeLa Cells; Humans; Microbial Sensitivity Tests; Models, Molecular; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2017 |
Design, Synthesis, and Antibacterial Evaluation of Oxazolidinones with Fused Heterocyclic C-Ring Substructure.
Topics: | 2017 |
Synthesis of 1,2,3-triazole linked 4(3H)-Quinazolinones as potent antibacterial agents against multidrug-resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Dose-Response Relationship, Drug; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Quinazolinones; Staphylococcal Infections; Structure-Activity Relationship; Triazoles | 2018 |
Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Coumarins; Crystallography, X-Ray; Drug Resistance, Bacterial; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Polyketide Synthases; Structure-Activity Relationship; Vero Cells | 2019 |
Synthesis and in vitro activity of asymmetric indole-based bisamidine compounds against Gram-positive and Gram-negative pathogens.
Topics: Anti-Bacterial Agents; Citrobacter freundii; Dose-Response Relationship, Drug; Escherichia coli; Furans; Indoles; Klebsiella; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas aeruginosa; Structure-Activity Relationship | 2020 |
Lead optimization of 8-(methylamino)-2-oxo-1,2-dihydroquinolines as bacterial type II topoisomerase inhibitors.
Topics: Anti-Bacterial Agents; Cell Survival; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Hep G2 Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Quinolines; Streptococcus pneumoniae; Structure-Activity Relationship; Topoisomerase II Inhibitors; Transcriptional Regulator ERG; Vancomycin-Resistant Enterococci | 2020 |
Synthesis and evaluation of new quinazoline-benzimidazole hybrids as potent anti-microbial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Benzimidazoles; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinazolines; Staphylococcus aureus; Structure-Activity Relationship | 2021 |
Design and synthesis of mycobacterial pks13 inhibitors: Conformationally rigid tetracyclic molecules.
Topics: Antitubercular Agents; Bacterial Proteins; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Polyketide Synthases; Quinolones; Structure-Activity Relationship | 2021 |
Optimization of TopoIV Potency, ADMET Properties, and hERG Inhibition of 5-Amino-1,3-dioxane-Linked Novel Bacterial Topoisomerase Inhibitors: Identification of a Lead with
Topics: Anti-Bacterial Agents; Dioxanes; DNA Gyrase; DNA Topoisomerase IV; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ether-A-Go-Go Potassium Channels; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2021 |
Synthesis and bioactivities of new N-terminal dipeptide mimetics with aromatic amide moiety: Broad-spectrum antibacterial activity and high antineoplastic activity.
Topics: Amides; Anti-Bacterial Agents; Antineoplastic Agents; Apoptosis; Cell Line; Cell Proliferation; Cell Survival; Dipeptides; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Escherichia coli; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Structure-Activity Relationship | 2022 |
Spermine-Conjugated Short Proline-Rich Lipopeptides as Broad-Spectrum Intracellular Targeting Antibacterial Agents.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Escherichia coli; Lipopeptides; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Proline; Spermine; Staphylococcus aureus | 2022 |
Amphiphilic cyclic peptide [W
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Gram-Negative Bacteria; Gram-Positive Bacteria; Meropenem; Microbial Sensitivity Tests; Peptides, Cyclic; Pseudomonas aeruginosa | 2022 |
Developing the Natural Prenylflavone Artocarpin from
Topics: Animals; Anti-Bacterial Agents; Artocarpus; Biofilms; Flavonoids; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Comparison of the in vitro activity of levofloxacin and other antimicrobial agents against vancomycin-susceptible and vancomycin-resistant Enterococcus species.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Enterococcus; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Vancomycin | 1995 |
Comparative in vitro activity of levofloxacin and ofloxacin against gram-positive bacteria.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacteria; Levofloxacin; Methicillin; Microbial Sensitivity Tests; Molecular Sequence Data; Ofloxacin; Penicillins; Staphylococcus; Streptococcus; Vancomycin | 1996 |
The comparative antimicrobial activity of levofloxacin tested against 350 clinical isolates of streptococci.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Erythromycin; Lactams; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillin Resistance; Streptococcus; Streptococcus pneumoniae; Time Factors; Vancomycin | 1996 |
Pharmacodynamics of once- or twice-daily levofloxacin versus vancomycin, with or without rifampin, against Staphylococcus aureus in an in vitro model with infected platelet-fibrin clots.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Blood Platelets; Colony Count, Microbial; Fibrin; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Staphylococcus aureus; Vancomycin | 1996 |
In vitro susceptibility of penicillin-resistant Streptococcus pneumoniae to levofloxacin, selection of resistant mutants, and time-kill synergy studies of levofloxacin combined with vancomycin, teicoplanin, fusidic acid, and rifampin.
Topics: Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Fusidic Acid; Levofloxacin; Mutation; Ofloxacin; Penicillin Resistance; Rifampin; Streptococcus pneumoniae; Teicoplanin; Vancomycin | 1996 |
[Isolation rate of Enterococcus spp. from surgical infections and their susceptibilities].
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Microbial; Enterococcus; Humans; Imipenem; Levofloxacin; Ofloxacin; Penicillins; Surgical Wound Infection; Thienamycins; Time Factors; Vancomycin | 1997 |
Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Endocarditis, Bacterial; Floxacillin; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1997 |
Antimicrobial susceptibility of viridans group streptococci.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Clindamycin; Drug Resistance, Microbial; Gentamicins; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rifampin; Streptococcal Infections; Streptococcus; Thienamycins; Vancomycin; Virginiamycin | 1997 |
Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-re
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Drug Resistance, Microbial; Fluoroquinolones; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Piperazines; Quinolines; Quinolones; Staphylococcus aureus; Vancomycin; Virginiamycin | 1999 |
Comparative in vitro activity of vancomycin and levofloxacin in combination with rifampin against planktonic versus sessile cells of Staphylococcus epidermidis.
Topics: Drug Therapy, Combination; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Staphylococcus epidermidis; Vancomycin | 2000 |
Comparative killing kinetics of the novel des-fluoro(6) quinolone BMS-284756, fluoroquinolones, vancomycin and beta-lactams.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; beta-Lactams; Enterobacteriaceae; Enterococcus faecalis; Fluoroquinolones; Indoles; Kinetics; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Quinolones; Staphylococcus aureus; Streptococcus; Vancomycin | 2001 |
Ciprofloxacin- and methicillin-resistant staphylococcus aureus susceptible to moxifloxacin, levofloxacin, teicoplanin, vancomycin and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Base Sequence; Ciprofloxacin; Drug Resistance, Multiple; Fluoroquinolones; Humans; Levofloxacin; Linezolid; Methicillin Resistance; Microbial Sensitivity Tests; Molecular Sequence Data; Moxifloxacin; Ofloxacin; Oxazolidinones; Polymerase Chain Reaction; Quinolines; Sensitivity and Specificity; Staphylococcus aureus; Teicoplanin; Vancomycin | 2001 |
Comparison of levofloxacin, alatrofloxacin, and vancomycin for prophylaxis and treatment of experimental foreign-body-associated infection by methicillin-resistant Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Disease Models, Animal; Fluoroquinolones; Foreign-Body Reaction; Guinea Pigs; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Rats; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2002 |
The activity of levofloxacin and comparator agents against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999 and 2000.
Topics: Africa; Americas; Anti-Bacterial Agents; Asia; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Europe; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae; Vancomycin | 2002 |
Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides.
Topics: Acetamides; Animals; Antibiotic Prophylaxis; Drug Resistance, Bacterial; Drug Therapy, Combination; Glycopeptides; Graft Rejection; Levofloxacin; Linezolid; Male; Microbial Sensitivity Tests; Ofloxacin; Oxazolidinones; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2003 |
Polymicrobial keratitis secondary to Burkholderia ambifaria, enterococcus, and staphylococcus aureus in a patient with herpetic stromal keratitis.
Topics: Amikacin; Burkholderia; Burkholderia Infections; Corneal Stroma; Drug Therapy, Combination; Enterococcus; Eye Infections, Bacterial; Gram-Positive Bacterial Infections; Humans; Keratitis, Herpetic; Levofloxacin; Male; Middle Aged; Ofloxacin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2003 |
Efficacy of vancomycin plus levofloxacin combination therapy for refractory pericarditis due to multiresistant Streptococcus pneumoniae.
Topics: Adult; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Levofloxacin; Male; Ofloxacin; Pericarditis; Pneumococcal Infections; Streptococcus pneumoniae; Vancomycin | 2003 |
Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Bacterial; Endocarditis, Bacterial; Floxacillin; Fluoroquinolones; Infusions, Intravenous; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rats; Staphylococcal Infections; Streptococcal Infections; Vancomycin; Viridans Streptococci | 2004 |
Linezolid, levofloxacin, and vancomycin against vancomycin-tolerant and fluoroquinolone-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic model.
Topics: Acetamides; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Ofloxacin; Oxazolidinones; Streptococcus pneumoniae; Vancomycin | 2003 |
In vitro effect of levofloxacin and vancomycin combination against high level aminoglycoside-resistant enterococci.
Topics: Aminoglycosides; beta-Lactam Resistance; Drug Resistance, Bacterial; Drug Therapy, Combination; Enterococcus faecalis; Enterococcus faecium; In Vitro Techniques; Levofloxacin; Ofloxacin; Vancomycin | 2004 |
An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Clindamycin; Community-Acquired Infections; Erythromycin; Female; Humans; Kentucky; Levofloxacin; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Oxacillin; Rifampin; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Tetracycline; Trimethoprim; Vancomycin | 2005 |
Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cloxacillin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Foreign-Body Reaction; Humans; Levofloxacin; Linezolid; Male; Methicillin; Microbial Sensitivity Tests; Ofloxacin; Oxazolidinones; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Doxycycline; Drug Therapy, Combination; Enzyme Inhibitors; Fosfomycin; Humans; In Vitro Techniques; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Ofloxacin; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Use of intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis.
Topics: Aged; Anti-Bacterial Agents; Carcinoma, Merkel Cell; Clostridioides difficile; Cytotoxins; Diarrhea; Ear Neoplasms; Enterocolitis, Pseudomembranous; Esomeprazole; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Levofloxacin; Male; Metronidazole; Ofloxacin; Skin Neoplasms; Thyroxine; Vancomycin | 2007 |
In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactams; Drug Therapy, Combination; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Ofloxacin; Pneumonia; Respiratory Tract Infections; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin | 2007 |
Bactericidal effect of intravitreal levofloxacin in an experimental model of endophthalmitis.
Topics: Animals; Anti-Bacterial Agents; Ceftazidime; Endophthalmitis; Female; Levofloxacin; Male; Microbial Sensitivity Tests; Models, Animal; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Vancomycin; Vitreous Body | 2008 |
[A case of phlegmonous gastritis which resolved with medical treatment].
Topics: Aged; Anti-Bacterial Agents; Cellulitis; Drug Therapy, Combination; Female; Gastritis; Humans; Levofloxacin; Male; Ofloxacin; Vancomycin | 2008 |
A new twist on an old problem: a case of pediatric meningitis caused by multidrug-resistant Streptococcus pneumoniae serotype 19A.
Topics: Anti-Bacterial Agents; Cefuroxime; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Infant; Levofloxacin; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Ofloxacin; Streptococcus pneumoniae; Vancomycin | 2008 |
Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models.
Topics: Administration, Topical; Animals; Anti-Bacterial Agents; Cefazolin; Ciprofloxacin; Colony Count, Microbial; Corneal Stroma; Corneal Ulcer; Disease Models, Animal; Drug Resistance, Bacterial; Eye Infections, Bacterial; Levofloxacin; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rabbits; Staphylococcal Infections; Staphylococcus aureus; Tobramycin; Vancomycin | 2010 |
Emergence of fluoroquinolone-resistant Streptococcus pneumoniae in Lebanon: a report of three cases.
Topics: Aged; Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Clarithromycin; Drug Resistance, Multiple, Bacterial; Humans; Imipenem; Lebanon; Levofloxacin; Male; Ofloxacin; Pneumococcal Infections; Pneumonia, Pneumococcal; Streptococcus pneumoniae; Vancomycin | 2010 |
Evidence for persisters in Staphylococcus epidermidis RP62a planktonic cultures and biofilms.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Biofilms; Drug Resistance, Bacterial; Levofloxacin; Microbial Sensitivity Tests; Microscopy, Confocal; Ofloxacin; Staphylococcus epidermidis; Surface Properties; Time Factors; Vancomycin | 2011 |
Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.
Topics: Acetamides; Bacterial Toxins; Ceftaroline; Cephalosporins; Clindamycin; Daptomycin; Electrophoresis, Gel, Pulsed-Field; Erythromycin; Exotoxins; Leukocidins; Levofloxacin; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Mupirocin; Ofloxacin; Oxacillin; Oxazolidinones; Polymerase Chain Reaction; Staphylococcus aureus; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; United States; Vancomycin | 2011 |
Sacroiliitis caused by Salmonella typhi: a case report.
Topics: Anti-Bacterial Agents; Blood Sedimentation; C-Reactive Protein; Diarrhea; Humans; Levofloxacin; Magnetic Resonance Imaging; Male; Ofloxacin; Pelvic Bones; Radiography; Sacroiliac Joint; Sacroiliitis; Salmonella typhi; Typhoid Fever; Vancomycin; Young Adult | 2011 |
Critical appraisal of air pouch infection model in rats.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Exudates and Transudates; Female; Gentamicins; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rats; Rats, Wistar; Staphylococcus aureus; Vancomycin | 2012 |
Characterizations of clinical isolates of clostridium difficile by toxin genotypes and by susceptibility to 12 antimicrobial agents, including fidaxomicin (OPT-80) and rifaximin: a multicenter study in Taiwan.
Topics: Anti-Infective Agents; Aza Compounds; Bacterial Proteins; Clostridioides difficile; Fluoroquinolones; Gemifloxacin; Glycosides; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Rifamycins; Rifaximin; Taiwan; Vancomycin | 2012 |
Phenotypic and molecular antibiotic resistance profile of Enterococcus faecalis and Enterococcus faecium isolated from different traditional fermented foods.
Topics: Ampicillin; Bacterial Proteins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterococcus faecalis; Enterococcus faecium; Erythromycin; Fermentation; Food Contamination; Food Microbiology; Genes, Bacterial; Gentamicins; Levofloxacin; Microbial Sensitivity Tests; Nitrofurantoin; Ofloxacin; Penicillins; Phenotype; Vancomycin | 2013 |
Susceptibility of methicillin-resistant Staphylococci clinical isolates to netilmicin and other antibiotics commonly used in ophthalmic therapy.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Chloramphenicol; Drug Resistance; Eye Infections, Bacterial; Fluoroquinolones; Humans; Levofloxacin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Moxifloxacin; Netilmicin; Quinolines; Staphylococcus epidermidis; Tobramycin; Vancomycin | 2013 |
Maxillary sinusitis after sinus lift due to Gemella morbillorum: antibiotic and surgical treatment.
Topics: Anti-Bacterial Agents; Bone Transplantation; Drug Hypersensitivity; Endoscopy; Female; Follow-Up Studies; Gemella; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Maxillary Sinusitis; Middle Aged; Penicillins; Reoperation; Rifampin; Sinus Floor Augmentation; Surgical Wound Infection; Vancomycin | 2013 |
Comparative study of the mutant prevention concentrations of vancomycin alone and in combination with levofloxacin, rifampicin and fosfomycin against methicillin-resistant Staphylococcus epidermidis.
Topics: Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Genes, Bacterial; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 2013 |
Clostridium difficile bacteremia.
Topics: Anti-Bacterial Agents; Bacteremia; Clostridioides difficile; Clostridium Infections; Humans; Intestinal Perforation; Levofloxacin; Lymphoma, Mantle-Cell; Male; Metronidazole; Middle Aged; Treatment Outcome; Vancomycin | 2013 |
[Endogenous endophthalmitis as a complication in erysipelas].
Topics: Antifungal Agents; Bacteremia; Ceftazidime; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Therapy, Combination; Endophthalmitis; Erysipelas; Eye Infections, Bacterial; Humans; Imipenem; Intertrigo; Leg; Levofloxacin; Male; Middle Aged; Obesity; Streptococcus agalactiae; Uveitis, Anterior; Vancomycin | 2013 |
Clostridium difficile in retail baskets, trolleys, conveyor belts, and plastic bags in Saudi Arabia.
Topics: ADP Ribose Transferases; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Clostridioides difficile; Cross-Sectional Studies; DNA, Bacterial; Drug Resistance, Bacterial; Enterotoxins; Equipment Contamination; Fomites; Food Handling; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Prevalence; Repressor Proteins; Ribotyping; RNA, Bacterial; Saudi Arabia; Vancomycin | 2014 |
Risk factors for gyrA and parC mutations in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Case-Control Studies; Cross Infection; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Female; Humans; Levofloxacin; Male; Middle Aged; Mutation; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Vancomycin | 2015 |
[Skin infection by community-acquired methicillin resistant Staphylococcus aureus with familial transmission].
Topics: Abscess; Adolescent; Adult; Anti-Bacterial Agents; Carrier State; Child; Community-Acquired Infections; Drug Therapy, Combination; Emergencies; Family Health; Humans; Levofloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Parents; Siblings; Staphylococcal Skin Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2016 |
Antimicrobial Susceptibility of Invasive Streptococcus pyogenes Isolates in Germany during 2003-2013.
Topics: Anti-Bacterial Agents; Cefotaxime; Chloramphenicol; Clindamycin; Epidemiological Monitoring; Germany; Humans; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Penicillins; Streptococcal Infections; Streptococcus pyogenes; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2015 |
Phototoxicity, Pseudoporphyria, and Photo-onycholysis Due to Voriconazole in a Pediatric Patient With Leukemia and Invasive Aspergillosis.
Topics: Ankle; Aspergillosis; Blister; Catheter-Related Infections; Cefepime; Cephalosporins; Cheilitis; Child; Cicatrix; Clindamycin; Dermatitis, Phototoxic; Echinocandins; Humans; Hypokalemia; Immunocompromised Host; Levofloxacin; Lipopeptides; Magnesium Deficiency; Male; Micafungin; Onycholysis; Photosensitivity Disorders; Porphyrias; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Vancomycin; Voriconazole | 2015 |
In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients.
Topics: Anti-Bacterial Agents; Daptomycin; Gram-Positive Bacteria; Humans; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Neoplasms; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2016 |
[Evaluation of the tissue diffusion capacity of antibiotics in lower limb ischaemia].
Topics: Aged; Anti-Bacterial Agents; Ceftazidime; Chromatography, High Pressure Liquid; Clindamycin; Female; Humans; Ischemia; Levofloxacin; Linezolid; Lower Extremity; Male; Meropenem; Microbial Sensitivity Tests; Prospective Studies; Skin; Thienamycins; Vancomycin | 2016 |
Dalbavancin Activity When Tested against Streptococcus pneumoniae Isolated in Medical Centers on Six Continents (2011 to 2014).
Topics: Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Penicillins; Streptococcus pneumoniae; Teicoplanin; Vancomycin | 2016 |
Differential Antimicrobial Susceptibilities of Granulicatella adiacens and Abiotrophia defectiva.
Topics: Abiotrophia; Anti-Infective Agents; Carnobacteriaceae; Cefepime; Cefotaxime; Cephalosporins; Clindamycin; Erythromycin; Levofloxacin; Microbial Sensitivity Tests; Penicillins; Vancomycin | 2016 |
3D scaffold with effective multidrug sequential release against bacteria biofilm.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Biofilms; Body Fluids; Calcification, Physiologic; Cell Line; Drug Liberation; Kinetics; Levofloxacin; Mice; Microbial Sensitivity Tests; Osteoblasts; Rifampin; Tissue Scaffolds; Vancomycin; X-Ray Diffraction | 2017 |
Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolated from the Chinese People's Liberation Army General Hospital in China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; China; Clindamycin; Clostridioides difficile; Clostridium Infections; Diarrhea; Drug Resistance, Bacterial; Female; Genotype; Hospitals, General; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Epidemiology; Multilocus Sequence Typing; Vancomycin; Young Adult | 2018 |
Peculiar purulence: Hypervirulent Klebsiella pneumoniae causing pyomyositis.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Liver Abscess; Male; Middle Aged; Penicillanic Acid; Phenotype; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyomyositis; Vancomycin | 2017 |
The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
Topics: Acinetobacter baumannii; Amikacin; Drug Resistance, Multiple, Bacterial; Enterococcus; Escherichia coli; France; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Klebsiella pneumoniae; Levofloxacin; Linezolid; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Streptococcus pneumoniae; Tigecycline; Vancomycin | 2018 |
Infective endocarditis caused by Lactococcus lactis subsp. lactis and Pediococcus pentosaceus: A case report and literature review.
Topics: Aged; Anti-Bacterial Agents; Endocarditis; Endocarditis, Bacterial; Humans; Lactococcus lactis; Levofloxacin; Male; Mitral Valve; Pediococcus pentosaceus; Treatment Outcome; Vancomycin | 2018 |
Selection of an appropriate empiric antibiotic regimen in hematogenous vertebral osteomyelitis.
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Empirical Research; Enterobacteriaceae; Female; Gene Expression; Humans; Levofloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Osteomyelitis; Retrospective Studies; Rifampin; Spine; Streptococcus; Vancomycin | 2019 |
The third national Japanese antimicrobial susceptibility pattern surveillance program: Bacterial isolates from complicated urinary tract infection patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Female; Fluoroquinolones; Humans; Japan; Klebsiella pneumoniae; Levofloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Proteus mirabilis; Pseudomonas aeruginosa; Urinary Tract Infections; Vancomycin; Young Adult | 2020 |
The tcdA-negative and tcdB-positive Clostridium difficile ST81 clone exhibits a high level of resistance to fluoroquinolones: a multi-centre study in Beijing, China.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; China; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; DNA Gyrase; Drug Resistance, Bacterial; Enterotoxins; Fluoroquinolones; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Molecular Epidemiology; Molecular Typing; Moxifloxacin; Vancomycin | 2020 |
Synergistic Effects of Thiosemicarbazides with Clinical Drugs against
Topics: Amoxicillin; Anti-Bacterial Agents; Cell Line; Cell Survival; DNA Gyrase; DNA Topoisomerase IV; Drug Combinations; Drug Synergism; Fibroblasts; Gene Expression; Gentamicins; Humans; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Semicarbazides; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin | 2020 |
The clinical value of two combination regimens in the Management of Patients Suffering from Covid-19 pneumonia: a single centered, retrospective, observational study.
Topics: Adult; Aged; Azithromycin; COVID-19; COVID-19 Drug Treatment; Drug Combinations; Drug Therapy, Combination; Female; Hospitalization; Humans; Hydroxychloroquine; Iran; Length of Stay; Levofloxacin; Lopinavir; Male; Meropenem; Middle Aged; Naproxen; Oseltamivir; Pneumonia, Viral; Prednisolone; Retrospective Studies; Ritonavir; Treatment Outcome; Vancomycin | 2020 |
Surgical infection prophylaxis prior to left ventricular assist device implantation: A survey of clinical practice.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Aztreonam; Cephalosporins; Cross-Sectional Studies; Drug Therapy, Combination; Fluconazole; Heart-Assist Devices; Humans; Levofloxacin; Prosthesis Implantation; Prosthesis-Related Infections; Rifampin; Surgical Wound Infection; Surveys and Questionnaires; Vancomycin | 2020 |
Streptococcus agalactiae in pregnant women: serotype and antimicrobial susceptibility patterns over five years in Eastern Sicily (Italy).
Topics: Ampicillin; Anti-Bacterial Agents; Clindamycin; Erythromycin; Female; Humans; Levofloxacin; Microbial Sensitivity Tests; Penicillins; Pregnancy; Serogroup; Sicily; Streptococcus agalactiae; Vagina; Vancomycin | 2020 |
Antimicrobial susceptibility and serotype distribution of Streptococcus agalactiae rectovaginal colonising isolates from pregnant women at a tertiary hospital in Pretoria, South Africa: An observational descriptive study.
Topics: Anti-Bacterial Agents; Clindamycin; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Levofloxacin; Microbial Sensitivity Tests; Penicillins; Pregnancy; Rectum; Serogroup; South Africa; Streptococcus agalactiae; Tertiary Care Centers; Vagina; Vancomycin | 2020 |
Vogesella perlucida-induced bacteremia in an advanced-age patient: first case report.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; Betaproteobacteria; Female; Humans; Levofloxacin; RNA, Ribosomal, 16S; Soft Tissue Infections; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Vancomycin | 2020 |
Streptococcus pneumoniae endophthalmitis: clinical settings, antibiotic susceptibility, and visual outcomes.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cataract; Cataract Extraction; Ceftriaxone; Cefuroxime; Corneal Ulcer; Endophthalmitis; Eye Enucleation; Eye Injuries; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Penicillins; Pneumococcal Infections; Retrospective Studies; Severity of Illness Index; Streptococcus pneumoniae; Taiwan; Tertiary Care Centers; Trabeculectomy; Treatment Outcome; Vancomycin; Vitrectomy | 2021 |
Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019.
Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Doripenem; Drug Resistance, Bacterial; Ertapenem; Humans; Levofloxacin; Linezolid; Meningitis, Pneumococcal; Microbial Sensitivity Tests; Penicillins; Pneumococcal Infections; Streptococcus pneumoniae; Taiwan; Vancomycin | 2022 |
Antibiotic-induced microbiome depletion alters renal glucose metabolism and exacerbates renal injury after ischemia-reperfusion injury in mice.
Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Blood Glucose; Gastrointestinal Microbiome; Gene Expression Regulation; Glucose; Glucose-6-Phosphatase; Kidney; Levofloxacin; Male; Mice; Mice, Inbred BALB C; Phosphoenolpyruvate Carboxykinase (ATP); Pyruvic Acid; Reperfusion Injury; Vancomycin | 2021 |
Bacteremia caused by accidental injection of Bacillus licheniformis microbiota modulator through the central venous catheter: A case report.
Topics: Aged; Anti-Bacterial Agents; Bacillaceae Infections; Bacillus licheniformis; Bacteremia; Central Venous Catheters; Female; Humans; Levofloxacin; Medical Errors; Microbiota; Vancomycin | 2022 |
Analysis of virulence genes, drug resistance detection, and pathogenicity in Enterococcus from farm animals.
Topics: Animals; Animals, Domestic; Anti-Bacterial Agents; Cattle; Cefotaxime; Chickens; Ciprofloxacin; Dogs; Drug Resistance; Drug Resistance, Bacterial; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Levofloxacin; Mice; Microbial Sensitivity Tests; Sulfamethoxazole; Swine; Vancomycin; Virulence; Virulence Factors | 2022 |
The Medium Composition Impacts
Topics: Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Osteomyelitis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2022 |
Sitafloxacin pharmacokinetics/pharmacodynamics against multidrug-resistant bacteria in a dynamic urinary tract infection in vitro model.
Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Escherichia coli; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Urinary Tract Infections; Vancomycin | 2022 |
Bacterial incidence and drug resistance from pathogens recovered from blood, cerebrospinal and pleural fluids in 2019-2020. Results of the Invifar network.
Topics: Anti-Bacterial Agents; Bacteria; Carbapenems; Drug Resistance; Escherichia coli; Humans; Incidence; Levofloxacin; Retrospective Studies; Vancomycin | 2023 |
[Distribution and Drug Resistance of Pathogens in Oral Mucositis Associated with Chemotherapy in Patients with Malignant Hematopathy].
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Cefuroxime; Drug Resistance, Bacterial; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Oral Ulcer; Penicillins; Stomatitis; Vancomycin | 2023 |
Study of the effect of administration of narasin or antibiotics on in vivo selection of a narasin- and multidrug-resistant Enterococcus cecorum strain.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Chickens; Levofloxacin; Oxytetracycline; Vancomycin | 2023 |
Eradication of Staphylococcus epidermidis within Biofilms: Comparison of Systemic versus Supratherapeutic Concentrations of Antibiotics.
Topics: Anti-Bacterial Agents; Biofilms; Daptomycin; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Rifampin; Staphylococcus epidermidis; Vancomycin | 2023 |
Current Prevalence of Antimicrobial Resistance in Okayama from a National Database between 2018 and 2021.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Drug Resistance, Bacterial; Escherichia coli; Humans; Klebsiella pneumoniae; Levofloxacin; Meropenem; Methicillin-Resistant Staphylococcus aureus; Prevalence; Vancomycin | 2023 |
In vitro activity of fidaxomicin and combinations of fidaxomicin with other antibiotics against Clostridium perfringens strains isolated from dogs and cats.
Topics: Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Clindamycin; Clostridioides difficile; Clostridium Infections; Clostridium perfringens; Diarrhea; Dog Diseases; Dogs; Erythromycin; Fidaxomicin; Humans; Imipenem; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Vancomycin | 2023 |